Oncostatin M Receptor-β Mutations Underlie Familial Primary Localized Cutaneous Amyloidosis

American Journal of Human Genetics

Volumn 82, Issue 1, 2008, Pages 73-80

  Arita, Ken ^a,b   South, Andrew P ^c   Hans Filho, Günter ^d   Sakuma, Thais Harumi ^d   Lai Cheong, Joey ^a   Clements, Suzanne ^a   Odashiro, Maçanori ^d   Odashiro, Danilo Nakao ^d   Hans Neto, Günter ^e   Hans, Nelise Ritter ^e   Holder, Maxine V ^c   Bhogal, Balbir S ^f   Hartshorne, Sian T ^g   Akiyama, Masashi ^b   Shimizu, Hiroshi ^b   McGrath, John A ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d FEDERAL UNIVERSITY OF MATO GROSSO DO SUL   (Brazil)

^e University for the Development of the State and the Region of Pantanal   (Brazil)

^f GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^g UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FIBRONECTIN; MITOGEN ACTIVATED PROTEIN KINASE 13; ONCOSTATIN M RECEPTOR BETA; ONCOSTATIN M RECEPTOR TYPE II; OSMR PROTEIN, HUMAN; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILIAL AMYLOIDOSIS; GENE MAPPING; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; KERATINOCYTE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; AMINO ACID SEQUENCE; BRAZIL; CHEMISTRY; CHROMOSOME 5; CULTURE TECHNIQUE; DOMINANT GENE; FEMALE; GENETICS; MALE; MISSENSE MUTATION; MOLECULAR GENETICS; PATHOLOGY; PEDIGREE; SEQUENCE HOMOLOGY; SOUTH AFRICA; UNITED KINGDOM;

AMINO ACID SEQUENCE; AMYLOIDOSIS, FAMILIAL; BRAZIL; CELL CULTURE TECHNIQUES; CHROMOSOMES, HUMAN, PAIR 5; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, DOMINANT; GREAT BRITAIN; HUMANS; KERATINOCYTES; MALE; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; ONCOSTATIN M RECEPTOR BETA SUBUNIT; PEDIGREE; SEQUENCE HOMOLOGY; SOUTH AFRICA;

EID: 38749092254     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajhg.2007.09.002     Document Type: Article

References (28)

1. Paus R., Schmelz M., Biro T., and Steinhoff M. Frontiers in pruritus research: scratching the brain for more effective itch therapy. J. Clin. Invest. 116 (2006) 1174-1186
2. Breathnach S.M. Amyloid and the amyloidosis of the skin. In: Burns T., Breathnach S., Cox C., and Griffiths C. (Eds). Rook's Textbook of Dermatology Volume 3 (2004), Blackwell Scientific, Oxford 57.36-57.51
3. Kumakiri M., and Hashimoto K. Histogenesis of primary localized cutaneous amyloidosis: sequential change of epidermal keratinocytes to amyloid via filamentous degeneration. J. Invest. Dermatol. 73 (1979) 150-162
4. Kobayashi H., and Hashimoto K. Amyloidogenesis in organ-limited cutaneous amyloidosis: an antigenic identity between epidermal keratin and skin amyloid. J. Invest. Dermatol. 80 (1983) 66-72
5. Schepis C., Siragusa M., Gagliardi M.E., Torre V., Cicciarello R., Albiero F., and Cavallari V. Primary macular amyloidosis: an ultrastructural approach to diagnosis. Ultrastruct. Pathol. 23 (1999) 279-284
6. Verga U., Fugazzola L., Cambiaghi S., Pritelli C., Alessi E., Cortelazzi D., Gangi E., and Beck-Peccoz P. Frequent association between MEN 2A and cutaneous lichen amyloidosis. Clin. Endocrinol. (Oxf.) 59 (2003) 156-161
7. Hofstra R.M., Sijmons R.H., Stelwagen T., Stulp R.P., Kousseff B.G., Lips C.J., Steijlen P.M., Van Woorst Vader P.C., and Buys C.H. RET mutation screening in familial cutaneous lichen amyloidosis and in skin amyloidosis associated with multiple endocrine neoplasia. J. Invest. Dermatol. 107 (1996) 215-218
8. Lee D.D., Huang J.Y., Wong C.K., Gagel R.F., and Tsai S.F. Genetic heterogeneity of familial primary cutaneous amyloidosis: lack of evidence for linkage with the chromosome 10 pericentromeric region in Chinese families. J. Invest. Dermatol. 107 (1996) 30-33
9. Seri M., Celli I., Betsos N., Claudiani F., Camera G., and Romeo G. A Cys634Gly substitution of the RET proto-oncogene in a family with recurrence of multiple endocrine neoplasia type 2A and cutaneous lichen amyloidosis. Clin. Genet. 51 (1997) 86-90
10. Lin M.W., Lee D.D., Lin C.H., Huang C.Y., Wong C.K., Chang Y.T., Liu H.N., Hsiao K.T., and Tsai S.F. Suggestive linkage of familial primary cutaneous amyloidosis to a locus on chromosome 1q23. Br. J. Dermatol. 152 (2005) 29-36
11. Lee D.D., Lin M.W., Chen I.C., Huang C.Y., Liu M.T., Wang C.R., Chang Y.T., Liu H.N., Liu T.T., Wong C.K., and Tsai S.F. Genome-wide scan identifies a susceptibility locus for familial primary cutaneous amyloidosis on chromosome 5p13.1-q11.2. Br. J. Dermatol. 155 (2006) 1201-1208
12. Rheinwald J.G. Human epidermal keratinocyte cell culture and xenograft systems: applications in the detection of potential chemical carcinogens and the study of epidermal transformation. Prog. Clin. Biol. Res. 298 (1989) 113-125
13. Halbert C.L., Demers G.W., and Galloway D.A. The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. J. Virol. 65 (1991) 473-478
14. Newton J.A., Jagjivan A., Bhogal B., McKee P.H., and McGibbon D.H. Familial primary cutaneous amyloidosis. Br. J. Dermatol. 112 (1985) 201-208
15. Hartshorne S.T. Familial primary cutaneous amyloidosis in a South African family. Clin. Exp. Dermatol. 24 (1999) 438-442
16. Dillon S.R., Sprecher C., Hammond A., Bilsborough J., Rosenfeld-Franklin M., Presnell S.R., Haugen H.S., Maurer M., Harder B., Johnston J., et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat. Immunol. 5 (2004) 752-760
17. Boniface K., Diveu C., Morel F., Pedretti N., Froger J., Ravon E., Garcia M., Venereau E., Preisser L., Guignouard E., et al. Oncostatin M secreted by skin infiltrating T lymphocytes is a potent keratinocyte activator involved in skin inflammation. J. Immunol. 178 (2007) 4615-4622
18. Kurth I., Horsten U., Pflanz S., Timmermann A., Kuster A., Dahmen H., Tacken I., Heinrich P.C., and Muller-Newen G. Importance of the membrane-proximal extracellular domains for activation of the signal transducer glycoprotein 130. J. Immunol. 164 (2000) 273-282
19. Heinrich P.C., Behrmann I., Haan S., Hermanns H.M., Muller-Newen G., and Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 374 (2003) 1-20
20. Mosley B., De Imus C., Friend D., Boiani N., Thoma B., Park L.S., and Cosman D. Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation. J. Biol. Chem. 271 (1996) 32635-32643
21. Finelt N., Gazel A., Gorelick S., and Blumenberg M. Transcriptional responses of human epidermal keratinocytes to Oncostatin-M. Cytokine 31 (2005) 305-313
22. Chattopadhyay S., Tracy E., Liang P., Robledo O., Rose-John S., and Baumann H. Interleukin-31 and oncostatin-M mediate distinct signaling reactions and response patterns in lung epithelial cells. J. Biol. Chem. 282 (2007) 3014-3026
23. Timmermann A., Küster A., Kurth I., Heinrich P.C., and Müller-Newen G. A functional role of the membrane-proximal extracellular domains of the signal transducer gp130 in heterodimerization with the leukemia inhibitory factor receptor. Eur. J. Biochem. 269 (2002) 2716-2726
24. Bando T., Morikawa Y., Komori T., and Senba E. Complete overlap of interleukin-31 receptor A and oncostatin M receptor beta in the adult dorsal root ganglia with distinct developmental expresion patterns. Neuroscience 142 (2006) 1263-1271
25. Sonkoly E., Muller A., Lauerma A.I., Pivarcsi A., Soto H., Kemeny L., Alenius H., Dieu-Nosjean M.C., Meller S., Rieker J., et al. IL-31: a new link between T cells and pruritus in atopic skin inflammation. J. Allergy Clin. Immunol. 117 (2006) 411-417
26. Chen R.H., Chang M.C., Su Y.H., Tsai Y.T., and Kuo M.L. Interleukin-6 inhibits transforming growth factor-beta-induced apoptosis through the phosphatidylinositol 3-kinase/Akt and signal transducers and activators of transcription 3 pathways. J. Biol. Chem. 274 (1999) 23013-23019
27. Mirmohammadsadegh A., Mota R., Gustrau A., Hassan M., Nambiar S., Marini A., Bojar H., Tannapfel A., and Hengge U.R. ERK1/2 is highly phosphorylated in melanoma metastases and protects melanoma cells from cisplatin-mediated apoptosis. J. Invest. Dermatol. 127 (2007) 2207-2215
28. Tamura S., Morikawa Y., Miyajima A., and Senba E. Expression of oncostatin M receptor β in a specific subset of nociceptive sensory neurons. Eur. J. Neurosci. 17 (2003) 2287-2298